GELDER MARK S. MD (Chief Medical Officer) purchased 2.38K shares of TRAWS PHARMA, INC. on the open market
Open‑market purchase worth $10.0K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/29/2021ACC: 0001179110-21-008981
Officer· Chief Medical Officer
Since Jun 2021
+2.38K
Net shares
Net buyer
$10.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
2.38K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+2.38K
Price / share
$4.20
Trade value
$10K
% of position
New position
9/28/2021
0.00→2.38K
Total
Net shares
+2.38K
Net value
$10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2021 | P · Purchase | +2.38K | $4.20 | $10K | New position | 0.00 | 2.38K |
| Total | +2.38K | $10K | ||||||
Derivative Transactions0
No derivative transactions reported